Achila OO,Fessahye N,Mengistu ST,Habtemikael NT,Werke WY,Zemichael FT,Leghese HN,Weldegegish TA,Tekeste TH,Garoy EY .2022 .A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea. Sci. Rep, 12(1) : 5567.
Alabkal RM,Medlinskiene K,Silcock J,Graham A .2023 .Impact of pharmacist-led interventions to improve clinical outcomes for adults with type 2 diabetes at risk of developing cardiovascular disease: A systematic review and meta-analysis. J. Pharm. Pract, 36(4) : 888-899.
Al-Ashwal FY,Sulaiman SAS,Sheikh Ghadzi SM,Kubas MA,Halboup A .2022 .Knowledge, attitude, perceived barriers, and practices among pharmacists regarding risk assessment of cardiovascular disease: A cross-sectional study in Yemen. Curr. Med. Res. Opin., 38(3) : 451-459.
Alavudeen SS,Easwaran V,Khan NA,Venkatesan K,Paulsamy P,Mohammed Hussein AT,Imam MT,Almalki ZS,Akhtar MS .2023 .Cardiovascular disease-related health promotion and prevention services by pharmacists in Saudi Arabia: How well are they prepared? Healthcare (Basel. , 11(11) : 1614.
Alhabib KF,Batais MA,Almigbal TH,Alshamiri MQ,Altaradi H,Rangarajan S,Yusuf S S .2020 .Demographic, behavioral and cardiovascular disease risk factors in the Saudi population: Results from the Prospective Urban Rural Epidemiology study (PURESaudi). BMC Public Health, 20(1) : 1213.
Alhazmi M,Bajuayfir A,Cheem E,Elrggal M,Ali M .2022 .Evaluation of current community pharmacist practice in Saudi Arabia A cross-sectional study from pharmacists' perspective (Part II). , 10(2) : 38.
Al-Jamei S,Abu Farha R,Zawiah M,Kadi T,AlSonidar A .2019 .Perceptions, knowledge and perceived barriers of Yemeni pharmacists and pharmacy technicians towards evidence‐based practice. J. Eval. Clin. Pract, 25(4) : 585-590.
Almaghaslah D .2023 .An analysis of pharmacy workforce capacity in Saudi Arabia. , 14 : 1219528.
Almaghaslah D,Alsayari A,Almanasef M,Asiri A .2021 .A cross-sectional study on pharmacy students' career choices in the light of Saudi Vision 2030: Will community pharmacy continue to be the most promising, but least preferred. sector? Int. J. Environ. Res. Public Health, 18(9) : 4589.
Almalki OS,Aldemerdash A,Al-Jazairi AS,Badreldin HA .2023 .Cardiology pharmacy practice in Saudi Arabia: Historical evolution, current status, and future directions. J. Am. Coll. Clin. Pharm., 6(6) : 588-596.
Almansour HA,Aloudah NM,Alhawassi TM,Chaar B,Krass I,Saini B .2020 .Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: A qualitative analysis. Saudi Pharm J., 28(5) : 529-537.
Almansour HA,Aloudah NM,Alhawassi TM,Chaar B,Krass I,Saini B,Pharm B .2021 .Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: What do policymakers and opinion leaders think? J. , 14(1) : 42.
Alrasheedy AA,Ibrahim MH,Alsahali S,Alfadly SO,Siddeeg K,Salah GB,Kassem LM,Alsaikhan R LM .2022 .Current state of career placement and employment opportunities for Doctor of Pharmacy graduates: A cross-sectional analysis from a college of pharmacy, Saudi Arabia. , 30(10) : 1479-1485.
Al-Ruthia Y,Alsenaidy MA,Alrabiah H,AlMuhaisen A,Alshehri M .2018 .The status of licensed pharmacy workforce in Saudi Arabia: A 2030 economic vision perspective. Hum Resour Health, 16(1) : .
Andrade C,Menon V,Ameen S .2020 .Designing and conducting knowledge, attitude, and practice surveys in psychiatry: Practical guidance. Indian J. Psychol. Med, 42(5) : 478-481.
Assiri A,Iqbal MJ,Gramish J,Assiri A,Meraya A,Alhossan A,Khobrani M .2021 .Pharmacists' satisfaction with their involvement in the management of COVID-19 patients in Saudi Arabia. , 29(1) : 85-90.
.2024 .-risk-assessment-and-management. Retrieved October 26, : .
Brown TJ,Todd A,O'Malley C,Moore HJ,Husband AK,Bambra C,Kasim A,Sniehotta FF,Steed L,Smith S,Nield L,Summerbell CD .2016 .Community pharmacy-delivered interventions for public health priorities: A systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open, 6(2) : e009828.
CDC. .2024 .Heart disease risk factors. Retrieved October, : .
Du Z and Qin Y .2023 .Dyslipidemia and cardiovascular disease: Current knowledge, existing challenges and new opportunities for management strategies. J. Clin. Med, 12(1) : 363.
Gagnon-Arpin I,Habib M,Al-Ayoubi F,Sutherland G,Dobrescu A,Villa G,AlHabib K G .2018 .Modelling the burden of cardiovascular disease in Saudi Arabia and the impact of reducing modifiable risk factors. J. Saudi Heart Assoc., 30(4) : 365.
Guembe MJ,Fernandez-Lazaro CI,Sayon-Orea C,Toledo E,Moreno-Iribas C .2020 .Risk for cardiovascular disease associated with metabolic syndrome and its components: A 13-year prospective study in the RIVANA cohort. , 19(1) : 195.
Ifeanyi Chiazor E,Evans M,van Woerden H .2015 .A systematic review of community pharmacists' interventions in reducing major risk factors for cardiovascular disease. Value Health Reg. Issues, 7 : 9-21.
Kandasamy G,Almaghaslah D,Almanasef M .2060 .An evaluation of continuing medical education among pharmacists in various pharmacy sectors in the Asir region of Saudi Arabia. Healthcare, 11(14) : .
Lloyd-Jones DM,Braun LT,Ndumele CE,Smith SC,Sperling LS,Virani SS,Blumenthal RS .2019 .Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report from the American Heart Association and American College of Cardiology. J. Am .Coll. Cardiol., 73(24) : 3153-3167.
Martínez-Mardones F,Fernandez-Llimos F,Benrimoj SI,Ahumada-Canale A,Plaza-Plaza JC,Garcia-Cardenas S Tonin F,V S Tonin F .2019 .Systematic review and meta-analysis of medication reviews conducted by pharmacists on cardiovascular diseases risk factors in ambulatory care. J. Am. Heart Assoc., 8(22) : e013627.
Ministry .2021 .. Statistical Yearbook. Retrieved October, : .
Nguyen TS,Nguyen TLH,Van Pham TT,Cao TBT,Nguyen VK,Hua S,Li SC .2018 .Effectiveness of a short training program for community pharmacists to improve knowledge and practice of asthma counselling - A simulated patient study. Respir. Med, 144 : 50-60.
Pope S,Hill H,Cardosi L,Henson L,Wasson M,Stallworth S,Ward K,Desselle SP,Hohmeier KC .2021 .Enhancing point-of-care testing through standardized training and redeployment of pharmacy technicians in the community setting. Explor. Res. Clin. Soc. Pharm., 2 : 100034.
Rababa'h AM,Ababneh M,Abedalqader NN,Altarabsheh SE .2023 .Knowledge, awareness and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents. Heliyon, 9(9) : e19288.
Raina S .2013 .Assessment of knowledge, attitude and practice in health care delivery. N. A. J. Med. Sci., 5(3) : 249.
Rasheed MK,Hasan SS,Altowayan WM,Farooqui M,Ud-Din Z .2023 .Community pharmacist's preparedness to provide patient-centred care in Saudi Arabia. , 31(6) : 801-807.
Samarasekera EJ,Clark CE,Kaur S,Patel RS,Mills J .2023 .Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance. BMJ (Clinical Research Ed.), 381 : 1028.
Santschi V .2011 .Impact of pharmacist care in the management of cardiovascular disease risk factors: A systematic review and meta-analysis of randomized trials. Arch. Intern. Med, 171(16) : 1441.
Saudi Health Council .2024 .Cardiovascular Disease: A Public Health Priority. 20a%20public%20health%20priority.pdf, : 20.
Sendekie A,Dagnaw AD,Dagnew EM .2023 .Pharmacists' involvements and barriers in the provision of health promotion services towards noncommunicable diseases: Community-based crosssectional study in Northwest Ethiopia. Arch. Public Health, 81(1) : 31.
SPRING .2023 .kap-survey-modelknowledge-attitudes-and-practices. Retrieved September, : .
Studziński K,Tomasik T,Krzysztoń J,Jóźwiak J,Windak A .2019 .Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: An overview of systematic reviews. BMC Cardiovasc Disord, 19(1) : 11.
Teo KK,Rafiq T .2021 .Cardiovascular risk factors and prevention: A perspective from developing countries. Can. J. Cardiol., 37(5) : 733-743.
Wang T,Tan JY B,Liu XL,Zhao I .2023 .Barriers and enablers to implementing clinical practice guidelines in primary care: An overview of systematic reviews. BMJ Open, 13(1) : e062158.
World Health Organization ,- .2024 .-pharmacists-on-thefrontline-of-health-care. Retrieved October 26, : .
World Health Organization ,- .2024 .Cardiovascular diseases (CVDs). Retrieved October, : .